Shares in Anika Therapeutics (NSDQ:ANIK) rose today after the company topped earnings expectations on Wall Street with its fourth quarter and full-year financial results, but missed sales estimates.
The Bedford, Mass.-based company posted profits of $8.1 million, or 55¢ per share, on sales of $29.3 million for the 3 months ended Dec. 31, for bottom-line loss of -0.2% on sales growth of 2.3% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Anika posts mixed Q4, FY17 results appeared first on MassDevice.
from MassDevice http://ift.tt/2op0WjS
Cap comentari:
Publica un comentari a l'entrada